vertex pharmaceuticals inc
(VRTX:NASDAQ GS)
As of 1:45 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).
Insiders at vertex pharmaceuticals inc (VRTX)
| Name (Connections) | Board Relationships | Title | Type of Board Member | Age |
| Jeffrey Leiden M.D., Ph.D. | 128 Relationships | Chairman, Chief Executive Officer and President | -- | 56 |
| Joshua Boger Ph.D. | 162 Relationships | Founder, Executive Director and Chairman of Science & Technology Committee | -- | 60 |
| Peter Mueller Ph.D. | 16 Relationships | Chief Scientific Officer, Executive Vice President of Global Research & Development and Member of The Scientific Advisory Board | -- | 55 |
Other Board Members on Board*
| Name (Connections) | Board Relationships | Type of Board Member | Primary Company | Age |
| Bruce Sachs | 65 Relationships | -- | Charles River Ventures | 52 |
| Elaine Ullian | 83 Relationships | -- | Vertex Pharmaceuticals Incorporated | 64 |
| Terrence Kearney | 16 Relationships | -- | Vertex Pharmaceuticals Incorporated | 57 |
| Paul Anderson Ph.D. | 95 Relationships | -- | Vertex Pharmaceuticals Incorporated | 73 |
| Roger Tsien Ph.D. | 31 Relationships | -- | Avelas BioSciences, Inc. | -- |
| Robert Schooley M.D. | 145 Relationships | -- | Vertex Pharmaceuticals Incorporated | -- |
| Jeremy Knowles Ph.D. | 65 Relationships | -- | Vertex Pharmaceuticals Incorporated | 76 |
| Steven Burakoff M.D. | 60 Relationships | -- | Vertex Pharmaceuticals Incorporated | 69 |
| Stephen Harrison Ph.D. | 16 Relationships | -- | Vertex Pharmaceuticals Incorporated | -- |
| Lewis Cantley Ph.D. | 67 Relationships | -- | Agios Pharmaceuticals, Inc. | -- |
| Wayne Riley M.D., MPH, MBA, FACP | 83 Relationships | -- | Pinnacle Financial Partners Inc. | 52 |
| Margaret McGlynn R.Ph | 58 Relationships | -- | International AIDS Vaccine Initiative, Inc | 52 |
| David Altshuler M.D., Ph.D. | 21 Relationships | -- | Vertex Pharmaceuticals Incorporated | 47 |
| Yuchun Lee | 88 Relationships | -- | General Catalyst Partners | 47 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| VRTX:US | $79.48 USD | +2.10 |  |
| Company | Last | Change |
| Alkermes PLC | $32.10 USD | +1.06 |
| BioMarin Pharmaceutical Inc | $64.85 USD | +2.42 |
| Jazz Pharmaceuticals Plc | $59.94 USD | +1.45 |
| Onyx Pharmaceuticals Inc | $93.70 USD | -0.64 |
| Regeneron Pharmaceuticals Inc | $261.40 USD | -2.24 |
| View Industry Companies | ||
Industry Analysis
VRTX
Industry Average
| Valuation | VRTX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 12.1x |
|
| Price/Book | 23.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 10.9x |
|
Post a JobJobs
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 21
- San Diego, CA | Vertex PharmaceuticalsPosted: May 21
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 14
- Cambridge, MA | Vertex PharmaceuticalsPosted: May 14
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
